These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2180230)

  • 1. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication.
    Linde K; Dentchev V; Bondarenko V; Marinova S; Randhagen B; Bratoyeva M; Tsvetanov Y; Romanova Y
    Vaccine; 1990 Feb; 8(1):25-9. PubMed ID: 2180230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shigella flexneri 2a and sonnei I vaccine with two attenuating markers: construction, tolerability and immunogenicity in 143 children aged 3-17 years.
    Linde K; Randhagen B; Beer J; Dentchev V; Marinova S; Vassilev T; Bratoyeva M
    Vaccine; 1993; 11(2):197-9. PubMed ID: 8438618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.
    Denchev V; Sumerska T; Marinova S; Vassilev T; Panova I; Linde K
    Acta Microbiol Hung; 1990; 37(4):359-66. PubMed ID: 2099082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes.
    Verma NK; Lindberg AA
    Vaccine; 1991 Jan; 9(1):6-9. PubMed ID: 2008803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of virulence plasmids and plasmid-associated outer membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli.
    Hale TL; Sansonetti PJ; Schad PA; Austin S; Formal SB
    Infect Immun; 1983 Apr; 40(1):340-50. PubMed ID: 6299962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enteric dysentery vaccines and their effectiveness in a rabbit intestinal loop model. I. The residual virulence of attenuated vaccinal strains of Shigella administered into the intestinal loops].
    Polotskiĭ IuE; Fedotova IuM; Rukhamina ML; Seliverstova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Nov; (11):32-6. PubMed ID: 7004003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.
    Noriega FR; Wang JY; Losonsky G; Maneval DR; Hone DM; Levine MM
    Infect Immun; 1994 Nov; 62(11):5168-72. PubMed ID: 7927802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model.
    Hartman AB; Venkatesan MM
    Infect Immun; 1998 Sep; 66(9):4572-6. PubMed ID: 9712824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A morphological evaluation of the harmlessness of noninvasive recombinant Shigella strains].
    Polotskiĭ IuE; Efremov VE; Bondarenko VM; Nastichkin IA; Belov AG; Kan IM; Smirnova GV; Romanova IuM; Kapustina AZ; Lavrenchuk MS
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):57-63. PubMed ID: 8067094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory safety testing of live dysentery vaccine strains (author's transl)].
    Lesniak SV; Levenbuk IS; Fedotova Y; Belaya M; Yu A; Sergeev VV; Jikidze EK; Kavtaradze KN; Elkina SL
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):87-97. PubMed ID: 4216254
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of DNA probes and the Sereny test for identification of invasive Shigella and Escherichia coli strains.
    Wood PK; Morris JG; Small PL; Sethabutr O; Toledo MR; Trabulsi L; Kaper JB
    J Clin Microbiol; 1986 Sep; 24(3):498-500. PubMed ID: 3531233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine.
    Lindberg AA; Karnell A; Pál T; Sweiha H; Hultenby K; Stocker BA
    Microb Pathog; 1990 Jun; 8(6):433-40. PubMed ID: 2266855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technological aspect of the production of live dysentery vaccines for oral administration.
    Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
    Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. II. Preliminary results of vaccination of adult volunteers and children aged 2-17 years.
    Dentchev V; Marinova S; Vassilev T; Bratoyeva M; Linde K
    Vaccine; 1990 Feb; 8(1):30-4. PubMed ID: 2180231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
    DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and characterization of a live attenuated Shigella flexneri 2a vaccine strain, sf301 Delta virG and dsbA33G].
    Yang XF; Zhou L; Zheng J; Si LS; Wang YL
    Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):748-52. PubMed ID: 16342769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.